Open house Arzneimittelrabattverträge Pomalidomid, ATC L04AX06
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Pomalidomid, ATC L04AX06
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
No estimated value or budget is disclosed. The actual uptake and revenue are unknown.
If a nationwide or regional discount agreement for the same substance enters into force, the open-house agreements are...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Sep 2026
- Non-exclusive discount agreements for the active substance Pomalidomid (ATC L04AX06).
- Contracts are in accordance with §130a Abs. 8 SGB V.
Show full summary
This is an open-house model (non-competitive) for non-exclusive discount agreements on Pomalidomid (ATC L04AX06) by AOK Bayern. All qualified pharmaceutical companies can join. Contracts run from 01.10.2024 to 30.09.2026. No estimated value is provided. Eligibility requires a self-declaration of reliability. Submission can be in paper (two originals) or electronically with a qualified electronic signature. Documents must be requested via the DTVP portal.
Risks
No estimated value or budget is disclosed. The actual uptake and revenue are unknown.
If a nationwide or regional discount agreement for the same substance enters into force, the open-house agreements are...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company.
Administrative
- Submit signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed self-declaration of reliability.
- Submission either in paper form (two originals) or electronically with a qualified electronic signature.
Buyer
Name
AOK Bayern - Die Gesundheitskasse
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Pomalidomid, ATC L04AX06
Non-exclusive discount agreements for Pomalidomid, ATC L04AX06, for patients of AOK Bayern. Open to all pharmaceutical companies that meet eligibility criteria.
Location
Duration
Category
Deadline
Award details
Selection criteria
Value note
Show original TED data
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 15 sie 2024
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 492240-2024
Documents (2)
Similar tenders
Spain – Microelectronic machinery and apparatus – Suministro e instalación de un equipo de litografía óptica de proyección en el ultravioleta profundo, destinado al Instituto de Microelectrónica de Barcelona de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Poland – Laboratory, optical and precision equipments (excl. glasses) – 76.2026 Dostawa sprzętu laboratoryjnego na potrzeby jednostek organizacyjnych Uniwersytetu Medycznego im. Piastów Śląskich we Wrocławiu
France – Market and economic research; polling and statistics – Appel d'offres relatif à des prestations de service sur l'écoute des usagers et collectivités desservies par le service public de l'eau
France – Telephone network maintenance services – Maintenance préventive et corrective des autocommutateurs téléphoniques privés
Hungary – Electrical supplies and accessories – Szabadvezetéki szerelvények II. 2026 - Démász
Estonia – Consultative engineering and construction services – Põhjamaade-Balti vesinikukoridori ja selle toimimiseks vajaliku taristu riigi eriplaneeringu koostamine Majandus- ja Kommunikatsiooniministeeriumile
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
No estimated value or budget is disclosed. The actual uptake and revenue are unknown.
If a nationwide or regional discount agreement for the same substance enters into force, the open-house agreements are...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications